An Unbiased View of Healthcare News
Novo CEO pressed by Senate to cut prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the corporate would think about new talks with insurers with regards to the list selling prices of Wegovy and copyright should they pledge to help keep the medicines on their own formularies.Sanders swiftly condemned the g